Mode
Text Size
Log in / Sign up

Supraglottic airway versus endotracheal intubation shows no overall survival benefit in out-of-hospital cardiac arrestStudy finds airway device choice doesn't change survival after cardiac arrest outside hospitals

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that for OHCA, advanced airway type may matter less than provider proficiency and minimizing CPR pauses.

This systematic review and meta-analysis examined the comparative effectiveness of two advanced airway management strategies in out-of-hospital cardiac arrest (OHCA). The analysis pooled data from eight clinical studies involving a total of 14,797 patients who experienced OHCA. All included studies were conducted in the out-of-hospital setting, primarily by emergency medical services personnel. The population consisted exclusively of patients with OHCA, though specific demographic characteristics, initial cardiac rhythms, or bystander intervention rates were not reported in the meta-analysis summary.

The intervention was the use of a supraglottic airway (SGA) device as the primary advanced airway. The comparator was endotracheal intubation (ETI). The meta-analysis did not specify the exact types of SGA devices used (e.g., laryngeal mask airway, i-gel) or provide details on the specific intubation protocols, including medication use for rapid sequence intubation. Dosing and procedural specifics were not reported, indicating the analysis focused on the broad comparison of the two airway management categories rather than specific techniques or devices within those categories.

The primary outcome was return of spontaneous circulation (ROSC). Overall, the meta-analysis found no significant difference in ROSC rates between the SGA and ETI groups. The risk difference (RD) was 0.02, with a 95% confidence interval (CI) of 0.0 to 0.04 and a p-value of 0.11. Since the CI includes zero and the p-value exceeds 0.05, this indicates no statistically significant effect of airway type on the overall likelihood of achieving ROSC. Absolute numbers for ROSC events in each group were not reported.

A key secondary outcome was survival to hospital discharge. Similar to the primary outcome, the analysis found no significant difference between groups. The risk difference for survival to hospital discharge was 0.01 (95% CI -0.01 to 0.02, p = 0.30). Again, the confidence interval crossing zero and the non-significant p-value indicate no detectable overall survival benefit for either airway strategy. The analysis also performed subgroup analyses based on whether the study protocols included additional training for providers. For ROSC, the subgroup where additional training was provided showed a statistically significant positive effect for SGA, with an RD of 0.02 (95% CI 0.0 to 0.04, p = 0.02). In contrast, the subgroup without additional training showed no significant effect (RD 0.01, 95% CI -0.05 to 0.01, p = 0.72).

The meta-analysis did not report specific data on safety, tolerability, or adverse events. Rates of adverse events such as aspiration, airway trauma, device failure, or misplaced tubes were not provided. Similarly, data on serious adverse events, discontinuations due to complications, or overall tolerability were not reported. This represents a significant gap in the evidence summary, as the comparative safety profile is a critical factor in clinical decision-making for airway management.

These results contribute to an ongoing debate in prehospital care regarding the optimal first-line advanced airway for OHCA. Prior landmark studies and trials have yielded mixed results, with some suggesting equivalence between SGA and ETI, while others have pointed to potential advantages or disadvantages for one strategy over the other, often influenced by provider skill level and system factors. This meta-analysis aligns with the body of evidence finding no clear mortality superiority for either technique overall, reinforcing that factors beyond the specific airway device—such as high-quality chest compressions and early defibrillation—likely have a greater impact on patient outcomes.

Key methodological limitations must be considered. The authors note that training programs differed between the investigated studies, making it difficult to isolate the effect of the device from the effect of the training. Furthermore, while statistical heterogeneity was reportedly not observed, clinical heterogeneity in terms of EMS system characteristics, provider experience levels, and specific protocols was likely present. Most importantly, the test for subgroup differences (comparing the training vs. no-training subgroups) was not statistically significant (p = 0.73). This undermines the reliability of the subgroup finding suggesting a benefit for SGA with additional training, as it indicates the observed difference between subgroups could be due to chance.

The clinical implications are nuanced. For systems and clinicians, the overall finding suggests that in the context of OHCA, the choice between SGA and ETI as the initial advanced airway may not be the pivotal factor determining ROSC or survival. System-level decisions might reasonably prioritize the technique in which local providers can achieve the highest success rate with the shortest interruption in chest compressions. The subgroup analysis, while not robust, hints that investment in structured, additional training for a chosen airway strategy could be more important than the choice of strategy itself. However, this should not be interpreted as evidence that SGA is superior when training is provided.

Several important questions remain unanswered. The lack of safety and adverse event data prevents a complete risk-benefit assessment. The optimal type and duration of 'additional training' are undefined. The impact of specific SGA device types (e.g., second-generation versus first-generation) compared to ETI is unclear. Furthermore, outcomes such as neurologically intact survival were not reported in this analysis, leaving a critical patient-centered endpoint unaddressed. Future research should focus on standardized training packages and report comprehensive safety outcomes to guide more definitive clinical and policy recommendations.

When someone's heart stops beating outside a hospital, every second counts. Paramedics rushing to the scene face a critical choice: how to secure the person's airway to help them breathe. For decades, the gold standard has been a procedure called endotracheal intubation—carefully threading a breathing tube down the windpipe. It's a complex skill. The alternative is using a simpler device called a supraglottic airway, which sits above the vocal cords and is generally quicker to place. This research matters because it asks a fundamental question for emergency medical services worldwide: does spending precious time on the more difficult procedure actually help more people survive? The answer affects how paramedics are trained and what equipment fills their ambulances.

The researchers didn't conduct a new experiment. Instead, they performed what's called a meta-analysis. They gathered and combined the results from eight previous clinical studies, creating a much larger pool of data to examine. In total, they looked at outcomes for 14,797 patients who suffered out-of-hospital cardiac arrests. In these real-world emergencies, paramedics had used either the traditional endotracheal intubation or a supraglottic airway device. The researchers then compared two key outcomes: whether patients had a return of spontaneous circulation (ROSC), which means their heart started beating again on its own, and whether they survived long enough to be discharged from the hospital.

Here's what they found when they crunched all the numbers together. Overall, there was no significant difference in outcomes between the two airway management techniques. The chance of a patient's heart restarting (ROSC) was not higher with one device over the other. Similarly, the rate of patients surviving to leave the hospital was statistically the same. The researchers reported a risk difference of 0.02 for ROSC and 0.01 for survival, which translates to a difference of 2 and 1 more people out of every 100, respectively—a difference so small it could easily be due to chance. However, the analysis took an interesting turn when they looked at a specific factor: paramedic training. In a subgroup of studies where paramedics received additional, specific training on using the supraglottic airway devices, there was a small but statistically significant positive effect on ROSC. In the subgroup without that extra training, no effect was seen. It's crucial to understand that the test to see if these subgroup results were truly different from each other was not itself statistically significant, meaning we can't be sure the training itself caused the difference.

The study did not report on specific safety concerns or adverse events related to either procedure. This is a common limitation in meta-analyses, as the original studies may not have collected or reported that data uniformly. The main caution from this research lies in its design and the nuances of the findings. This is a meta-analysis, which means it reports observed associations from past studies; it does not prove that using one device causes better outcomes than another. The promising finding about additional training comes with important caveats: the training programs differed between the studies, and the statistical test comparing the 'training' and 'no training' subgroups was not significant. This means we should not overstate the role of training based on this single analysis.

What does this mean for patients and communities right now? This large review provides reassuring evidence that, on a population level, the choice between these two advanced airway techniques does not appear to be a major factor in determining whether someone survives a cardiac arrest outside the hospital. For emergency medical systems, it suggests that equipping crews with supraglottic airways—which are often easier and faster to use—is a reasonable strategy that is not linked to worse survival rates. The hint about the value of specific training is an important point for further research but is not a definitive guide for practice today. The most critical factors for survival remain early recognition of cardiac arrest, immediate bystander CPR, and rapid defibrillation. This study helps clarify that once professional help arrives, the specific advanced airway method used may be less important than other elements of care.

What this means for you:
In cardiac arrests outside hospitals, survival rates were similar whether paramedics used a simple or complex breathing tube.

Study Details

Study typeMeta analysis
Sample sizen = 14,797
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: The optimal airway management strategy in out-of-hospital cardiac arrest has been controversial. Whereas endotracheal intubation currently represents the gold standard, supraglottic airway securement may provide advantages with respect to handling out-of-hospital cardiac arrest. OBJECTIVES: This meta-analysis of randomized controlled and clinical studies evaluates the effects of the advanced airway strategy (supraglottic vs. endotracheal intubation) on return of spontaneous circulation (ROSC). METHODS: This systematic review and meta-analysis was performed based on a predefined protocol. Literature search included PubMed, Web of Science, and the Cochrane Library. RESULTS: A total of eight clinical studies including 14,797 patients were analyzed. Pooled analysis indicated no higher rate of ROSC in patients treated with supraglottic airway vs. endotracheal intubation (risk difference [RD] 0.02, 95% confidence interval [CI] 0.0-0.04, p = 0.11) and no higher rate of survival to hospital discharge (RD 0.01, 95% CI -0.01-0.02, p = 0.30). Interestingly, additional training indicated a significant effect of supraglottic airway on ROSC, whereas the subgroup difference was not significant (RD [additional training] 0.02, 95% CI 0.0-0.04, p = 0.02, RD [no additional training] 0.01, 95% CI -0.05-0.01, p = 0.72, test for subgroup differences, p = 0.73). Training programs differed between the investigated studies. Statistical heterogeneity was not observed. CONCLUSION: Overall, the type of advanced airway (supraglottic vs. endotracheal intubation) did not impact ROSC or survival to hospital discharge. However, after additional training, supraglottic airway use may have a positive effect on ROSC in out-of-hospital cardiac arrest.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.